Skip to main content
SpringerLink
Log in

Target-specific therapy requires target-specific populations in the treatment of renal cell carcinoma

  • Main topic
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Suggested reading

  1. Bui M, Seigson D, Han K, Pantuck A, Dorey F, Huang Y, Horvath S, Leibovich B, Chopra S, Liao S, Stanbridge E, Lerman M, Palotie A, Figlin R, Belldegrun A (2003) Carbonic anhydrase IX is an independent predictor of survival in advanced renal cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9:802–811

    CAS  PubMed  Google Scholar 

  2. Pantuck AJ, Zeng G, Belldegrun AS, Figlin RA (2004) Pathobiology, prognosis and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway. Clin Cancer Res (in press)

  3. Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, Topalian SL, Steinberg SM, Chen HX, Rosenberg SA (2003) A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. New Engl J Med 349:427–434

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Zisman A, Pantuck AJ, Dorey F, Chao D, Gitlitz BJ, Moldawer N, Lazarovici D, de Kernion JB, Figlin RA, Belldegrun AS (2002) A mathematical model to predict individual survival for patients with renal cell carcinoma. J Clin Oncol 20:1368–1374

    Article  PubMed  Google Scholar 

Download references

Conflict of interest:

No information supplied

Author information

Authors and Affiliations

  1. Department of Urology, School of Medicine, UCLA, Los Angeles, CA, USA

    Robert A. Figlin, H. Alvin & C. L. Meinhardt

  2. Department of Urology, School of Medicine, UCLA, 10833 LeConte Avenue, Los Angeles, CA 90095, USA

    Robert A. Figlin

Authors
  1. Robert A. Figlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Alvin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. L. Meinhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert A. Figlin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Figlin, R.A., Alvin, H. & Meinhardt, C.L. Target-specific therapy requires target-specific populations in the treatment of renal cell carcinoma. Urologe 43 (Suppl 3), 144–145 (2004). https://doi.org/10.1007/s00120-004-0607-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-004-0607-5

Keywords

Search

Navigation